This Neuroathology Core (NP Core) has two components: One NPCore component is located at the University of California in San Francisco (UCSF) and the other is located at the University of Pennsylvania Medical Center (UPMC). Three main reasons for this arrangement are: (1) The overall theme of this ADRC is longitudinal comparisons of human frontotemporal lobar degenerative diseases (FTLD) and prion diseases with Alzheimer's disease, mild cognitive impairment, and normal control subjects enrolled in the ADRC. (2) UCSF has already had a long-standing FTDL collaboration with the UPML Laboratory. (3) Both Laboratories use unique morphological, immunohistochemical, and neurochemical methods to study these diseases, which makes this two component NP Core the ideal neuropathology adjunct to an ADRC that will emphasize studies of FTLDs and prion diseases. The UCSF NP Core assumes the main responsibility for obtaining autopsy brains, because the the subjects are recruited by the Clinical Core at UCSF and will likely die in the vicinity of UCSF. As such, the UCSF NP Core will perform the autopsies, obtain brain samples for research from the fresh brain, bank the research samples, prepare the remainder of the brain for standard neurohistopathological analysis, and send selected research and diagnostic brain samples from suspected FTLD cases to the UPMC NP Core component. Research samples, 2x2x1 cm, will be dissected bilaterally from the uncut brain at 15 cortical sites (Brodmann areas) known to either degenerate or be spared in FTLDs. In addition, similar samples will be obtained from the rotral (anterior) cigulate gyrus and the rostral insular cortex. These samples will be divided in half with one half immersion-fixed in paraformaldehyde for possible immunohistochemical studies and the other half frozen for neurochemical and molecular studies. These will be banked in the UCSF NPCore for use by investigators of the ADRC or other suitable outside investigators. The UCSF NP Core will use selected samples of this tissue to perform stereological estimates of synapse densities and nerve cell numbers. The rest of the brain and brainstem is formalin-fixed for neurohistopathological analysis to determine diagnosis using accepted diagnostic criteria.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG023501-04
Application #
7407534
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2007-04-01
Budget End
2008-03-31
Support Year
4
Fiscal Year
2007
Total Cost
$247,879
Indirect Cost
Name
University of California San Francisco
Department
Type
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Tse, Kai-Hei; Cheng, Aifang; Ma, Fulin et al. (2018) DNA damage-associated oligodendrocyte degeneration precedes amyloid pathology and contributes to Alzheimer's disease and dementia. Alzheimers Dement 14:664-679
Gallagher, Damien; Kiss, Alex; Lanctot, Krista et al. (2018) Depression and Risk of Alzheimer Dementia: A Longitudinal Analysis to Determine Predictors of Increased Risk among Older Adults with Depression. Am J Geriatr Psychiatry 26:819-827
Schaffert, Jeff; LoBue, Christian; White, Charles L et al. (2018) Traumatic brain injury history is associated with an earlier age of dementia onset in autopsy-confirmed Alzheimer's disease. Neuropsychology 32:410-416
Casaletto, Kaitlin B; Staffaroni, Adam M; Elahi, Fanny et al. (2018) Perceived Stress is Associated with Accelerated Monocyte/Macrophage Aging Trajectories in Clinically Normal Adults. Am J Geriatr Psychiatry 26:952-963
Orr, Anna G; Lo, Iris; Schumacher, Heike et al. (2018) Istradefylline reduces memory deficits in aging mice with amyloid pathology. Neurobiol Dis 110:29-36
Haaksma, Miriam L; Calderón-Larrañaga, Amaia; Olde Rikkert, Marcel G M et al. (2018) Cognitive and functional progression in Alzheimer disease: A prediction model of latent classes. Int J Geriatr Psychiatry 33:1057-1064
Watson, Christa L; Possin, Katherine; Allen, I Elaine et al. (2018) Visuospatial Functioning in the Primary Progressive Aphasias. J Int Neuropsychol Soc 24:259-268
Casaletto, K B; Elahi, F M; Fitch, R et al. (2018) A comparison of biofluid cytokine markers across platform technologies: Correspondence or divergence? Cytokine 111:481-489
Tan, Chin Hong; Fan, Chun Chieh; Mormino, Elizabeth C et al. (2018) Polygenic hazard score: an enrichment marker for Alzheimer's associated amyloid and tau deposition. Acta Neuropathol 135:85-93
Mok, Sue-Ann; Condello, Carlo; Freilich, Rebecca et al. (2018) Mapping interactions with the chaperone network reveals factors that protect against tau aggregation. Nat Struct Mol Biol 25:384-393

Showing the most recent 10 out of 590 publications